Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

Clinical trial NCT06904872 · RECRUITING

Trial details

NCT number: NCT06904872
Sponsor: Napo Therapeutics, S.p.A.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Short Bowel Syndrome Malabsorption Syndromes Short Gut Syndrome Post-Op Complication Functional Gastrointestinal Disorders

Start date: 2025-05-29
Primary completion: 2027-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.